<DOC>
	<DOCNO>NCT00774085</DOCNO>
	<brief_summary>The purpose study assess treatment outcome data patient receive treatment long-acting injectable risperidone .</brief_summary>
	<brief_title>An Observational Study Assess Treatment &amp; Outcomes Data Patients Receiving Long-Acting Injectable Risperidone</brief_title>
	<detailed_description>This observational ( study patients/participants observe ) multicentre ( multiple site ) study . This one-country arm multinational study . This study consist 2 year retrospective ( study patient identify documented backward time 2 year prospective ( study patient identify follow forward time outcome study ) study period medication utilization review do , determine medication usage pattern outcomes associate use risperidone long act , clinical practice . Usage risperidone accord label recommend study . The planned recruitment period 6 month . Retrospective observation 2 year hospitalization history least 1 year medication usage . Total duration prospective observation patient complete follow-up 24 month . Data collection follow period schedule every 3 month Â± 2 week . In addition , study propose Belgium satisfy demand Belgian Reimbursement Authorities collect clinical data impact risperidone long act treatment compliance , number hospitalization potential prevention relapse . Also , data provide documentation switch oral parenteral treatment . Data pool different physician and/or country . The objective study : collect clinical outcome data request Belgian Reimbursement Authorities ; prospectively ass medication usage pattern document clinical efficacy long-term treatment outcome risperidone long act , naturalistic setting ; collect retrospective data , compare risperidone long act ; document reason initiate risperidone ; collect data switch treatment risperidone long act .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Patient start longacting injectable risperidone treatment agreement doctor patient Ambulatory patient chronically fulltime hospitalize patient . Fulltime hospitalization moment inclusion maximal 6 month The treatment treat indication accord local label Patient give informed consent agreement local legislation Patient participate another medication relate study , chronically fulltime hospitalize patient , accord treat physician perspective discharge within plan observation period Patient suffering treatment resistant schizophrenia Pregnant breastfeeding female female plan pregnancy within two year</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Risperdal Consta</keyword>
	<keyword>Propective</keyword>
	<keyword>Retrospective</keyword>
	<keyword>Mental disorder</keyword>
	<keyword>Observational</keyword>
</DOC>